Sino Biopharmaceutical Ltd
HKEX:1177

Watchlist Manager
Sino Biopharmaceutical Ltd Logo
Sino Biopharmaceutical Ltd
HKEX:1177
Watchlist
Price: 3.33 HKD 1.22%
Market Cap: 61.1B HKD
Have any thoughts about
Sino Biopharmaceutical Ltd?
Write Note

Sino Biopharmaceutical Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sino Biopharmaceutical Ltd
Cash from Operating Activities Peer Comparison

Comparables:
G
512
U
3933
C
570
C
3320
H
13

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sino Biopharmaceutical Ltd
HKEX:1177
Cash from Operating Activities
ÂĄ6.1B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
12%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Cash from Operating Activities
HK$2.4B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
13%
U
United Laboratories International Holdings Ltd
HKEX:3933
Cash from Operating Activities
ÂĄ2.4B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
5%
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Cash from Operating Activities
ÂĄ1.2B
CAGR 3-Years
-16%
CAGR 5-Years
1%
CAGR 10-Years
21%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Cash from Operating Activities
HK$18.3B
CAGR 3-Years
39%
CAGR 5-Years
18%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Cash from Operating Activities
-$47m
CAGR 3-Years
24%
CAGR 5-Years
-1%
CAGR 10-Years
N/A

See Also

What is Sino Biopharmaceutical Ltd's Cash from Operating Activities?
Cash from Operating Activities
6.1B CNY

Based on the financial report for Jun 30, 2024, Sino Biopharmaceutical Ltd's Cash from Operating Activities amounts to 6.1B CNY.

What is Sino Biopharmaceutical Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
12%

Over the last year, the Cash from Operating Activities growth was 22%.

Back to Top